Lacquaniti, A., Pasqualetti, P., Tocco, T. C. d., Campo, S., Rovito, S., Bucca, M., . . . Monardo, P. (2020). Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up. Kidney Res Clin Pract.

Lacquaniti, Antonio, Patrizio Pasqualetti, Teresa Casuscelli di Tocco, Susanna Campo, Stefania Rovito, Maurizio Bucca, Antonino Ragusa, and Paolo Monardo. "Ferric Carboxymaltose Versus Ferric Gluconate in Hemodialysis Patients: Reduction of Erythropoietin Dose in 4 Years of Follow-up." Kidney Res Clin Pract 2020.

Lacquaniti, Antonio, et al. "Ferric Carboxymaltose Versus Ferric Gluconate in Hemodialysis Patients: Reduction of Erythropoietin Dose in 4 Years of Follow-up." Kidney Res Clin Pract 2020.